Takeda Pharmaceutical Company Limited
- TAK
- NYSE
- Drug Manufacturers - Specialty & Generic
- Specialty Biopharmaceuticals (GI/Rare Disease/Oncology)
$19.67
Today +1.13%Quote Oct 16, 2026, 08:00 PM UTC
+3.25%over the last month
Max drawdown −6.5%From 1-month high 0.0%3 months +15.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$62.18B
Quote Oct 16
Next earnings
Oct 29
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$19.42
1.3% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about TAKPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Drug Manufacturers - Specialty & Generic
Employees
47,029